Reference priceKRW ₩7,128.00Original source price: INR 440.00. Converted estimates are available by currency selection.
| Brand | Iqirvo |
|---|---|
| Manufacturer | IPSEN PHARMA S.A. |
| Prescription required | Yes |
Iqirvo 80mg Filmtabletten,1 x 30St(Elafibranor)
Elafibranor
Description
Iqirvo 80mg Filmtabletten,1 x 30St(Elafibranor) is a medicine catalog record in the MediPriceHub database. Active ingredient: Elafibranor. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: IPSEN PHARMA S.A.. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Cholestatic liver disease. Pack information: 80 30. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
IQIRVO is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have had an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA. This indication is approved under accelerated approval based on reduction of alkaline phosphatase (ALP) [see Clinical Studies ] . Improvement in survival or prevention of liver decompensation events have not been demonstrated. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).How to Use
Use Elafibranor under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: Elafibranor. Pack size: 80 30. Pack unit: bottle. Manufacturer: IPSEN PHARMA S.A.. Origin country: Germany. Source category: Medicine Library > Liver and Gallbladder Diseases > Cholestatic liver disease. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Possible adverse effects vary by active ingredient, dose, route, treatment duration, and patient condition. Common issues may include gastrointestinal symptoms, headache, dizziness, fatigue, rash, allergic reactions, or abnormal laboratory tests. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.이 정보는 참고용입니다. 의약품 사용 전 의료 전문가와 상담하세요.